![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
News
In Fight Against COVID-19 Ensovibep Paves A Concrete Path
The phase 2 EMPATHY top-line data which is a DARP in therapeutic antiviral used in the COVID-19 treatment suggests that measurable and meaningful benefits...
News
COVID-19 Vaccines May Need Updation For Omicron- WHO Body
The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be...
News
Leading Pulmonologists in India have started using Molnupiravir for mild COVID-19 cases; consider it the best bet for early treatment of COVID-19
With questions being raised on the safety of the only available approved oral antiviral pill for COVID-19 - Molnupiravir, health experts of the country have...
Press Releases
Novavax and Serum Institute of India File for EUA of Novavax COVID-19 Vaccine in South Africa
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII),...
Press Releases
GSK and Vir Biotechnology announce US government agreement to purchase additional supply of sotrovimab, authorised for the early treatment of COVID-19
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the US Government will purchase an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody for...
News
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
Adamis Pharmaceuticals Corporation announced the submission of a Fast Track Application to the U.S. Food and Drug Administration (FDA) for Tempol for the treatment...
Techno Trends
COVID-19 And Collaborative Approach of Research And Health
Although we cannot say that it was unheard of, collaboration on the basis of interdisciplinary and interprofessional elements has always been crucial in any...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read